Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 18, Issue -, Pages 3-16
Publisher
Wiley
Online
2016-10-13
DOI
10.1111/dom.12744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis
- (2016) Byron J. Hoogwerf et al. Cardiovascular Diabetology
- Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
- (2016) Romina Lomonaco et al. DIABETES CARE
- Glucodynamics of long-acting basal insulin peglispro compared with insulin glargine at steady state in patients with type 1 diabetes: substudy of a randomized crossover trial
- (2016) L. A. Morrow et al. DIABETES OBESITY & METABOLISM
- Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials
- (2016) Henry Ginsberg et al. DIABETES OBESITY & METABOLISM
- Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
- (2016) K. Cusi et al. DIABETES OBESITY & METABOLISM
- Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4
- (2016) T. Blevins et al. DIABETES OBESITY & METABOLISM
- Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial
- (2016) M. J. Davies et al. DIABETES OBESITY & METABOLISM
- A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naïve patients with type 2 diabetes: the IMAGINE 6 trial
- (2016) G. Grunberger et al. DIABETES OBESITY & METABOLISM
- Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
- (2016) R. M. Bergenstal et al. DIABETES OBESITY & METABOLISM
- A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1
- (2016) S. Garg et al. DIABETES OBESITY & METABOLISM
- Similar HbA1c reduction and hypoglycaemia with variable- vs fixed-time dosing of basal insulin peglispro in type 1 diabetes: IMAGINE 7 study
- (2016) S. Garg et al. DIABETES OBESITY & METABOLISM
- Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
- (2016) Julio Rosenstock et al. DIABETES OBESITY & METABOLISM
- Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes
- (2015) Justin M. Gregory et al. DIABETES
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
- (2015) An Tang et al. DIABETES CARE
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
- (2015) John B. Buse et al. DIABETES CARE
- Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes
- (2015) R. Herring et al. DIABETES OBESITY & METABOLISM
- Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical Trials
- (2015) Edward J. Bastyr et al. Diabetes Technology & Therapeutics
- Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
- (2014) Robert R. Henry et al. DIABETES CARE
- Single-dose pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 in healthy subjects
- (2014) Vikram P. Sinha et al. JOURNAL OF CLINICAL PHARMACOLOGY
- How to Avoid Being Surprised by Hepatotoxicity at the Final Stages of Drug Development and Approval
- (2013) Arie Regev Clinics in Liver Disease
- Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
- (2013) M. C. Moore et al. DIABETES
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes
- (2013) M. Blanco et al. DIABETES & METABOLISM
- Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM
- (2013) S. J. Jacober et al. DIABETES OBESITY & METABOLISM
- Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus
- (2013) V. P. Sinha et al. DIABETES OBESITY & METABOLISM
- The Future of Basal Insulin
- (2013) Viral N. Shah et al. Diabetes Technology & Therapeutics
- Insulin Stacking Versus Therapeutic Accumulation: Understanding the Differences
- (2013) Tim Heise et al. Endocrine Practice
- Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study
- (2012) J. Rosenstock et al. DIABETES CARE
- A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes
- (2012) R. M. Bergenstal et al. DIABETES CARE
- Insulin effects in muscle and adipose tissue
- (2011) George Dimitriadis et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Generalized allergy due to zinc in insulin treated with zinc-free insulin
- (2010) Ines Ben Ammar et al. ACTA DIABETOLOGICA
- Regulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
- (2010) Yulia Komarova et al. Annual Review of Physiology
- Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes
- (2009) F. Smeeton et al. DIABETOLOGIA
- Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors
- (2009) H. Hauner et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now